Prediction the clinical outcomes of cancer patients after peptide vaccination.

e14295Background: Neoantigen vaccines can activate T-cells that specifically kill tumor cells. However, most vaccine peptides, selected either as HLA-binders or as HLA-presented epitopes, do not in...